Loading...

Mark Magbanua

TitleSpecialist
SchoolUCSF School of Medicine
DepartmentMedicine
Address2340 Sutter Street
San Francisco CA 94115
Phone415-514-3969
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San FranciscoPostdoctoral ReseacherHematology Oncology
    University of California DavisPhDPlant Biology
    University of California DavisMScInternational Agricultural Development
    Kansas State University MScPlant Pathology
    University of the Philippines at Los BanosBSc Biology/GeneticsInstitute of Biological Sciences
    Collapse Awards and Honors
    2012• ASCO Foundation Merit Award, Genitourinary Cancers Symposium
    2011• ASCO Foundation Merit Award, Breast Cancer Symposium
    2010• AACR Minority Scholar Award in Cancer Research, SABCS
    2009• ASCO Foundation Merit Award, Genitourinary Cancers Symposium
    2009• ASCO Foundation Merit Award, Breast Cancer Symposium
    2008• Best Scientific Poster Award, Breast Oncology Program, UC San Francisco
    2003• Outstanding Graduate Teaching Award, UC Davis
    2002• Professors for the Future Fellowship

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lee JS, Magbanua M, Park JW. Circulating tumor cells in breast cancer: applications in personalized medicine. Breast Cancer Res Treat. 2016 Dec; 160(3):411-424. PMID: 27761678.
      View in: PubMed
    2. Lee JS, Melisko ME, Magbanua M, Kablanian AT, Scott JH, Rugo HS, Park JW. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Breast Cancer Res Treat. 2015 Nov; 154(2):339-49. PMID: 26520840.
      View in: PubMed
    3. Magbanua M, Pugia M, Lee JS, Jabon M, Wang V, Gubens M, Marfurt K, Pence J, Sidhu H, Uzgiris A, Rugo HS, Park JW. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. PLoS One. 2015; 10(10):e0141166. PMID: 26496203; PMCID: PMC4619669.
      View in: PubMed, PubMed Central
    4. Magbanua M, Das R, Polavarapu P, Park JW. Approaches to isolation and molecular characterization of disseminated tumor cells. Oncotarget. 2015 Oct 13; 6(31):30715-29. PMID: 26378808.
      View in: PubMed
    5. Magbanua M, Wolf DM, Yau C, Davis SE, Crothers J, Au A, Haqq CM, Livasy C, Rugo HS, Esserman L, Park JW, van 't Veer LJ. Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response. Breast Cancer Res. 2015; 17:73. PMID: 26021444; PMCID: PMC4479083.
      View in: PubMed, PubMed Central
    6. Kelley RK, Magbanua M, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls. BMC Cancer. 2015; 15:206. PMID: 25884197; PMCID: PMC4399150.
      View in: PubMed, PubMed Central
    7. Magbanua M, Carey LA, DeLuca A, Hwang J, Scott JH, Rimawi MF, Mayer EL, Marcom PK, Liu MC, Esteva FJ, Park JW, Rugo HS. Circulating tumor cell analysis in metastatic triple-negative breast cancers. Clin Cancer Res. 2015 Mar 1; 21(5):1098-105. PMID: 25524311.
      View in: PubMed
    8. Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua M, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW. Expression profiling of circulating tumor cells in metastatic breast cancer. Breast Cancer Res Treat. 2015 Jan; 149(1):121-31. PMID: 25432738.
      View in: PubMed
    9. Magbanua M, Park JW. Advances in genomic characterization of circulating tumor cells. Cancer Metastasis Rev. 2014 Sep; 33(2-3):757-69. PMID: 24867683.
      View in: PubMed
    10. Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, Rubashkin MG, Magbanua M, Thorn KS, Davidson MW, Rugo HS, Park JW, Hammer DA, Giannone G, Bertozzi CR, Weaver VM. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 2014 Jul 17; 511(7509):319-25. PMID: 25030168; PMCID: PMC4487551.
      View in: PubMed, PubMed Central
    11. Magbanua M, Roy R, Sosa EV, Hauranieh L, Kablanian A, Eisenbud LE, Ryazantsev A, Au A, Scott JH, Melisko M, Park JW. Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors. Genom Data. 2014 Dec; 2:60-2. PMID: 26484071; PMCID: PMC4535622.
      View in: PubMed, PubMed Central
    12. Magbanua M, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. PMID: 24504435; PMCID: PMC3990413.
      View in: PubMed, PubMed Central
    13. Magbanua M, Melisko M, Roy R, Sosa EV, Hauranieh L, Kablanian A, Eisenbud LE, Ryazantsev A, Au A, Scott JH, Park JW. Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. Cancer Res. 2013 Dec 1; 73(23):7134-43. PMID: 24142343.
      View in: PubMed
    14. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua M, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-20. PMID: 24051140.
      View in: PubMed
    15. Kelley RK, Hwang J, Magbanua M, Watt L, Beumer JH, Christner SM, Baruchel S, Wu B, Fong L, Yeh BM, Moore AP, Ko AH, Korn WM, Rajpal S, Park JW, Tempero MA, Venook AP, Bergsland EK. A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. Br J Cancer. 2013 Oct 1; 109(7):1725-34. PMID: 24022191; PMCID: PMC3790192.
      View in: PubMed, PubMed Central
    16. Magbanua M, Park JW. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling. Methods. 2013 Dec 1; 64(2):114-8. PMID: 23896286.
      View in: PubMed
    17. Magbanua M, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res. 2013 Jan 1; 73(1):30-40. PMID: 23135909; PMCID: PMC4085329.
      View in: PubMed, PubMed Central
    18. Magbanua M, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, Ryan CJ, Park JW. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer. 2012; 12:78. PMID: 22373240; PMCID: PMC3395839.
      View in: PubMed, PubMed Central
    19. Magbanua M, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. PMID: 21912659; PMCID: PMC3164676.
      View in: PubMed, PubMed Central
    20. Galvez AF, Huang L, Magbanua M, Dawson K, Rodriguez RL. Differential expression of thrombospondin (THBS1) in tumorigenic and nontumorigenic prostate epithelial cells in response to a chromatin-binding soy peptide. Nutr Cancer. 2011; 63(4):623-36. PMID: 21526452; PMCID: PMC3210036.
      View in: PubMed, PubMed Central
    21. Chan JM, Weinberg V, Magbanua M, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. PMID: 21103921; PMCID: PMC3002170.
      View in: PubMed, PubMed Central
    22. Lang JE, Magbanua M, Scott JH, Makrigiorgos GM, Wang G, Federman S, Esserman LJ, Park JW, Haqq CM. A comparison of RNA amplification techniques at sub-nanogram input concentration. BMC Genomics. 2009; 10:326. PMID: 19619282; PMCID: PMC2724417.
      View in: PubMed, PubMed Central
    23. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua M, Marlin R, Yglecias L, Carroll PR, Blackburn EH. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008 Nov; 9(11):1048-57. PMID: 18799354.
      View in: PubMed
    24. Ornish D, Magbanua M, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8369-74. PMID: 18559852; PMCID: PMC2430265.
      View in: PubMed, PubMed Central
    Mark's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (128) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (29) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP